Concepedia

The SNM Practice Guideline for Somatostatin Receptor Scintigraphy 2.0

Helena Balon, Tracy L. Brown, S. J. Goldsmith, Edward B. Silberstein, E. P. Krenning, O. Lang, Gary Dillehay, J. Tarrance, Matthew G. Johnson, Michael G. Stabin

Journal of Nuclear Medicine Technology · 2011 · 85 citations · 31 references

DOIFull text

Open access

Concepts

Abstract

VOICE Credit: This activity has been approved for 1.0 VOICE (Category A) credit. For CE credit, participants can access this activity on page 325 or on the SNM Web site (http://www.snm.org/ce_online) through December 31, 2013. You must answer 80% or the questions correctly to receive 1.0 CEH (Continuing Education Hour) credit.

References

31

International Commission on Radiological Protection

Radiology · 1969 · 2.2K citations

, , +5

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

Michael Gabriel, Clemens Decristoforo, Dorota Kendler et al. · Journal of Nuclear Medicine · 2007 · 1K citations · Full text

Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary and Metastatic Gastrinomas: A Prospective Study

Fathia Gibril, James C. Reynolds, John L. Doppman et al. · Annals of Internal Medicine · 1996 · 443 citations

Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma

Henri Timmers, Clara C. Chen, Jorge A. Carrasquillo et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 389 citations · Full text

AACE/AAES MEDICAL/SURGICAL Guidelines for Clinical Practice: Management of Thyroid Carcinoma

Rhoda H. Cobin, Hossein Gharib, Donald A. Bergman et al. · Endocrine Practice · 2001 · 370 citations

, , +5